MARA Holdings
MARA
Coinbase
COIN
Meta Platforms
META
Vale SA
VALE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
BCRX BioCryst Pharmaceuticals
- 7.645
- -0.085-1.10%
Trading Jan 24 13:48 ET
1.58BMarket Cap-12.53P/E (TTM)
7.850High7.550Low991.59KVolume7.640Open7.730Pre Close7.61MTurnover0.51%Turnover RatioLossP/E (Static)207.13MShares8.88052wk High-3.38P/B1.48BFloat Cap4.03052wk Low--Dividend TTM193.26MShs Float37.250Historical High--Div YieldTTM3.88%Amplitude0.600Historical Low7.670Avg Price1Lot Size
About BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Company Profile
SymbolBCRX
Company NameBioCryst Pharmaceuticals
Listing DateMar 3, 1994
Issue Price6.50
Founded1986
CEOMr. Jon P. Stonehouse
MarketNASDAQ
Employees536
Fiscal Year Ends12-31
Address4505 Emperor Boulevard,Suite 200
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703-8457
Phone1-919-859-1302
Websitehttp://www.biocryst.com
Company Executives
- Name
- Position
- Salary
- Jon P. Stonehouse
- Director, President and Chief Executive Officer
- 4.78M
- Anthony Doyle
- Chief Financial Officer, Treasurer and Interim Principal Accounting Officer
- 1.79M
- Dr. Helen M. Thackray, M.D.
- Chief Research and Development Officer
- 2.39M
- Alane Barnes
- Chief Legal Officer and Corporate Secretary
- 1.93M
- Charles K. Gayer
- Chief Commercial Officer
- 1.74M
- Dr. Nancy J. Hutson, PhD
- Chairman of the Board
- 470.30K
- Vincent J. Milano
- Independent Director
- 434.82K
- Dr. Steven Galson, M.D.
- Independent Director
- 424.40K
- Theresa M. Heggie
- Independent Director
- 433.57K
- George B. Abercrombie
- Independent Director
- 432.74K
- Machelle Sanders
- Independent Director
- 423.15K
- Alan G. Levin
- Independent Director
- 434.54K
- Dr. Amy McKee
- Independent Director
- 422.32K
- Stephen J. Aselage
- Independent Director
- 446.90K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.